Toshiya Inui
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
IS AS NEEDED THERAPY WITH AN INHALED BUDESONIDE/FORMOTEROL COMBINATION ONLY WHEN SYMPTOMATIC AS AN OPTION IN THE MANAGEMENT OF PATIENTS WITH MILD ASTHMA?
Journal: Arerugi = [Allergy]
Published: October 13, 2025
Investigation of the Number of Oral Bacteria in Patients with Chronic Obstructive Pulmonary Disease, Asthma, and Asthma and Chronic Obstructive Pulmonary Disease Overlap.
Journal: Internal medicine (Tokyo, Japan)
Published: March 25, 2025
Immune checkpoint inhibitor-related haemophagocytic lymphohistiocytosis in a patient with non-small cell lung carcinoma.
Journal: Respirology case reports
Published: February 16, 2023
Effect of Mirtazapine for the Prevention of Nausea and Vomiting in Patients With Thoracic Cancer Receiving Platinum-based Chemotherapy.
Journal: Anticancer research
Published: January 18, 2023
Soluble ST2 enhances IL-33-induced neutrophilic and pro-type 2 inflammation in the lungs.
Journal: Allergy
Published: March 21, 2022
Classifications of moderate to severe asthma phenotypes in Japan and analysis of serum biomarkers: A Nationwide Cohort Study in Japan (NHOM Asthma Study).
Journal: Allergology international : official journal of the Japanese Society of Allergology
Published: January 18, 2022
A Pilot Study of Transdermal Application of Diphenhydramine to the Nasal Ala in Patients with Allergic Rhinitis and Asthma.
Journal: The Tokai journal of experimental and clinical medicine
Published: November 26, 2021
Cancer cachexia as a determinant of efficacy of first-line pembrolizumab in patients with advanced non-small cell lung cancer.
Journal: Molecular and clinical oncology
Published: November 19, 2021
Ruxolitinib inhibits poly(I:C) and type 2 cytokines-induced CCL5 production in bronchial epithelial cells: A potential therapeutic agent for severe eosinophilic asthma.
Journal: Immunity, inflammation and disease
Published: July 05, 2020
Pseudomonas aeruginosa-derived flagellin stimulates IL-6 and IL-8 production in human bronchial epithelial cells: A potential mechanism for progression and exacerbation of COPD.
Journal: Experimental lung research
Published: September 14, 2019
Bronchial epithelial cells produce CXCL1 in response to LPS and TNFα: A potential role in the pathogenesis of COPD.
Journal: Experimental lung research
Published: January 25, 2019
Serum sST2 levels predict severe exacerbation of asthma.
Journal: Respiratory research
Published: April 03, 2018
Last Updated: 09/26/2026